Sfoglia per Autore
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer?
2012 Federico, Alessandro; Romano, Marco; Gravina, A. G.; DI DOMENICO, Marina; Marra, M.; Zappavigna, S.; D’Armiento, F. P.; Ippolito, R.; Tuccillo, C.; Grieco, P.; Novellino, E.; Loguercio, Carmelina; Caraglia, Michele
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms
2012 Ferro, M; Giuberti, G; Zappavigna, S; Perdonà, S; Facchini, G; Sperlongano, Pasquale; Porto, S; Di Lorenzo, G; Buonerba, C; Abbruzzese, A; Altieri, V; Caraglia, Michele
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study.
2012 Marra, M; Salzano, G; Leonetti, C; Porru, M; Franco, Renato; Zappavigna, S; Liguori, G; Botti, G; Chieffi, Paolo; Lamberti, Monica; Vitale, G; Abbruzzese, A; La Rotonda, Mi; De Rosa, G; Caraglia, Michele
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells.
2012 Sanges, C; Scheuermann, C; Zahedi, Rp; Sickmann, A; Lamberti, A; Migliaccio, N; Baljuls, A; Marra, M; Zappavigna, S; Reinders, J; Rapp, U; Abbruzzese, A; Caraglia, Michele; Arcari, P.
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress.
2012 Lamberti, Monica; Porto, S; Marra, M; Zappavigna, S; Grimaldi, A; Feola, D; Pesce, D; Naviglio, Silvio; Spina, Annamaria; Sannolo, Nicola; Caraglia, Michele
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells.
2012 Vitale, G; Zappavigna, S; Marra, M; Dicitore, A; Meschini, S; Condello, M; Arancia, G; Castiglioni, S; Maroni, P; Bendinelli, P; Piccoletti, R; van Koetsveld, Pm; Cavagnini, F; Budillon, A; Abbruzzese, A; Hofland, Lj; Caraglia, Michele
Nanoparticles releasing zoledronic acid have antitumor activity against experimental models of human glioblastoma
2013 Leonetti, ; C, ; Porru, ; M, ; Artuso, ; S, ; Zappavigna, S; Luce, ; A, ; Salzano, ; G, ; Lusa, ; S, ; De, Rosa; G, ; Caraglia, ; M,
Il recettore dell'Urotensina come bersaglio per la veicolazione di agenti antitumorali incapsulati in nano vettori
2013
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO
2013 Luce, A; Zappavigna, S; Balestrieri, Maria Luisa; D'Onofrio, N; Porru, M; Salzano, G; Lusa, S; Leonetti, C; De Rosa, G; Caraglia, Michele
Autophagic cell death: A new frontier in cancer research
2013 Zappavigna, S.; Luce, A.; Vitale, G.; Merola, N.; Facchini, S.; Caraglia, M.
Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy?
2013 Dicitore, A; Caraglia, Michele; Colao, A; Zappavigna, S; Mari, D; Hofland, Lj; Persani, L; Vitale, G.
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation
2013 Perna, A; Sepe, I; Lanza, D; Capasso, R; Zappavigna, S; Capasso, G; Caraglia, M; Ingrosso, D.
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain.
2013 Caraglia, Michele; Luongo, Livio; Salzano, G; Zappavigna, S; Marra, M; Guida, Francesca; Lusa, S; Giordano, C; DE NOVELLIS, Vito; Rossi, Francesco; Abbruzzese Saccardi, A; De Rosa, G; Maione, Sabatino
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance.
2013 Troiani, Teresa; Zappavigna, S; Martinelli, Erika; Addeo, Sr; Stiuso, Paola; Ciardiello, Fortunato; Caraglia, Michele
Interleukin 18: Friend or foe in cancer.
2013 Palma, G; Barbieri, A; Bimonte, S; Palla, M; Zappavigna, S; Caraglia, Michele; Ascierto, Pa; Ciliberto, G; Arra, C.
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC.
2013 Addeo, R; Zappavigna, Silvia; Luce, Amalia; Facchini, S; Caraglia, Michele
Emerging pathways as individualized therapeutic target of multiple myeloma.
2013 Misso, Gabriella; Zappavigna, S; Castellano, M; De Rosa, G; Di Martino, Mt; Tagliaferri, P; Tassone, P; Caraglia, Michele
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers.
2014 Lamberti, Monica; Zappavigna, S; Sannolo, Nicola; Porto, S; Caraglia, Michele
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid.
2014 Porru, M; Zappavigna, S; Salzano, G; Luce, A; Stoppacciaro, A; Balestrieri, Maria Luisa; Artuso, S; Lusa, S; De Rosa, G; Leonetti, C; Caraglia, Michele
Erlotinib: early clinical development in brain cancer.
2014 Addeo, R; Zappavigna, S; Parlato, Ciro; Caraglia, Michele
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? | 1-gen-2012 | Federico, Alessandro; Romano, Marco; Gravina, A. G.; DI DOMENICO, Marina; Marra, M.; Zappavigna, S.; D’Armiento, F. P.; Ippolito, R.; Tuccillo, C.; Grieco, P.; Novellino, E.; Loguercio, Carmelina; Caraglia, Michele | |
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms | 1-gen-2012 | Ferro, M; Giuberti, G; Zappavigna, S; Perdonà, S; Facchini, G; Sperlongano, Pasquale; Porto, S; Di Lorenzo, G; Buonerba, C; Abbruzzese, A; Altieri, V; Caraglia, Michele | |
New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study. | 1-gen-2012 | Marra, M; Salzano, G; Leonetti, C; Porru, M; Franco, Renato; Zappavigna, S; Liguori, G; Botti, G; Chieffi, Paolo; Lamberti, Monica; Vitale, G; Abbruzzese, A; La Rotonda, Mi; De Rosa, G; Caraglia, Michele | |
Raf kinases mediate the phosphorylation of eukaryotic translation elongation factor 1A and regulate its stability in eukaryotic cells. | 1-gen-2012 | Sanges, C; Scheuermann, C; Zahedi, Rp; Sickmann, A; Lamberti, A; Migliaccio, N; Baljuls, A; Marra, M; Zappavigna, S; Reinders, J; Rapp, U; Abbruzzese, A; Caraglia, Michele; Arcari, P. | |
5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. | 1-gen-2012 | Lamberti, Monica; Porto, S; Marra, M; Zappavigna, S; Grimaldi, A; Feola, D; Pesce, D; Naviglio, Silvio; Spina, Annamaria; Sannolo, Nicola; Caraglia, Michele | |
The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. | 1-gen-2012 | Vitale, G; Zappavigna, S; Marra, M; Dicitore, A; Meschini, S; Condello, M; Arancia, G; Castiglioni, S; Maroni, P; Bendinelli, P; Piccoletti, R; van Koetsveld, Pm; Cavagnini, F; Budillon, A; Abbruzzese, A; Hofland, Lj; Caraglia, Michele | |
Nanoparticles releasing zoledronic acid have antitumor activity against experimental models of human glioblastoma | 1-gen-2013 | Leonetti, ; C, ; Porru, ; M, ; Artuso, ; S, ; Zappavigna, S; Luce, ; A, ; Salzano, ; G, ; Lusa, ; S, ; De, Rosa; G, ; Caraglia, ; M, | |
Il recettore dell'Urotensina come bersaglio per la veicolazione di agenti antitumorali incapsulati in nano vettori | 1-gen-2013 | - | |
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO | 1-gen-2013 | Luce, A; Zappavigna, S; Balestrieri, Maria Luisa; D'Onofrio, N; Porru, M; Salzano, G; Lusa, S; Leonetti, C; De Rosa, G; Caraglia, Michele | |
Autophagic cell death: A new frontier in cancer research | 1-gen-2013 | Zappavigna, S.; Luce, A.; Vitale, G.; Merola, N.; Facchini, S.; Caraglia, M. | |
Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? | 1-gen-2013 | Dicitore, A; Caraglia, Michele; Colao, A; Zappavigna, S; Mari, D; Hofland, Lj; Persani, L; Vitale, G. | |
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation | 1-gen-2013 | Perna, A; Sepe, I; Lanza, D; Capasso, R; Zappavigna, S; Capasso, G; Caraglia, M; Ingrosso, D. | |
Stealth liposomes encapsulating zoledronic acid: a new opportunity to treat neuropathic pain. | 1-gen-2013 | Caraglia, Michele; Luongo, Livio; Salzano, G; Zappavigna, S; Marra, M; Guida, Francesca; Lusa, S; Giordano, C; DE NOVELLIS, Vito; Rossi, Francesco; Abbruzzese Saccardi, A; De Rosa, G; Maione, Sabatino | |
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance. | 1-gen-2013 | Troiani, Teresa; Zappavigna, S; Martinelli, Erika; Addeo, Sr; Stiuso, Paola; Ciardiello, Fortunato; Caraglia, Michele | |
Interleukin 18: Friend or foe in cancer. | 1-gen-2013 | Palma, G; Barbieri, A; Bimonte, S; Palla, M; Zappavigna, S; Caraglia, Michele; Ascierto, Pa; Ciliberto, G; Arra, C. | |
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC. | 1-gen-2013 | Addeo, R; Zappavigna, Silvia; Luce, Amalia; Facchini, S; Caraglia, Michele | |
Emerging pathways as individualized therapeutic target of multiple myeloma. | 1-gen-2013 | Misso, Gabriella; Zappavigna, S; Castellano, M; De Rosa, G; Di Martino, Mt; Tagliaferri, P; Tassone, P; Caraglia, Michele | |
Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers. | 1-gen-2014 | Lamberti, Monica; Zappavigna, S; Sannolo, Nicola; Porto, S; Caraglia, Michele | |
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid. | 1-gen-2014 | Porru, M; Zappavigna, S; Salzano, G; Luce, A; Stoppacciaro, A; Balestrieri, Maria Luisa; Artuso, S; Lusa, S; De Rosa, G; Leonetti, C; Caraglia, Michele | |
Erlotinib: early clinical development in brain cancer. | 1-gen-2014 | Addeo, R; Zappavigna, S; Parlato, Ciro; Caraglia, Michele |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile